- Is Trump defiling the U.S. flag in this MAGA dude’s artwork? Sunday 4:41 PM
- White woman claims she invented sleep bonnets, selling them for $100 Sunday 4:03 PM
- Even real cats are transfixed by the enigma that is the ‘Cats’ trailer Sunday 3:04 PM
- Wait, how tall is Peppa Pig? Sunday 1:55 PM
- Twitter suspends Iranian state media outlets for harassing members of a religious minority Sunday 1:06 PM
- Pro-MAGA pageant queen stripped of title over ‘offensive’ tweets Sunday 11:52 AM
- Marvel unveiled its Phase 4 plans at San Diego Comic-Con Sunday 9:16 AM
- How a queer Instagram is helping fight the opioid epidemic in Appalachia Sunday 6:30 AM
- Philadelphia to fire 13 officers for racist, violent Facebook posts Saturday 6:12 PM
- Nick Offerman is so down to play every single role in ‘Cats’ Saturday 4:27 PM
- Woman documents how airport staff broke her wheelchair Saturday 3:04 PM
- Funeral home allegedly posted photos of woman’s dead body on social media Saturday 1:56 PM
- Alinity Divine is being investigated after throwing her cat during stream (updated) Saturday 12:04 PM
- ‘Comedians In Cars Getting Coffee’ returns with Seinfeld making a racist joke about China Saturday 10:26 AM
- YouTubers Eugenia Cooney and Shane Dawson make a joint comeback Saturday 9:06 AM
It uses Bluetooth to send data to a smartphone app.
You didn’t swallow your sensor today, did you? That’s how a conversation with your angry doctor could start in the near future.
The Food and Drug Administration on Monday approved the first “digital pill” in the U.S. that uses sand-grain-sized embedded sensors to track when a patient takes their medication. The pill, called Abilify MyCite, sends information to a patch patients wear on the left side of their rib cage, which then transmits data to a smartphone app.
The sensor, made of copper, magnesium, and silicon—safe ingredients found in foods—triggers an electrical signal when touched by acid. A few minutes after ingestion, the pill contacts stomach acid and sends a signal to the Band-Aid-like patch. The patch then transmits time and dosage information to a smartphone app using standard Bluetooth protocol.
Privacy groups are concerned the pills will be used to punish patients who don’t take them, while others question why the first approved pill is used to treat patients with schizophrenia who can become paranoid about doctors.
“You would think that, whether in psychiatry or general medicine, drugs for almost any other condition would be a better place to start than a drug for schizophrenia,” Dr. Paul Appelbaum, director of law, ethics, and psychiatry at Columbia University, told the New York Times.
Patients can sign consent forms to allow doctors and four other people, like caretakers or family members, to receive a time log of when they take their medication. The hope is that the pill will solve problems with patients not taking their medications, which the IMS Institute estimates costs the industry more than $200 million each year.
Abilify MyCite is a collaboration between the company that makes the medicine, Otsuka, and the sensor creator Proteus Digital Health. Abilify is used to treat schizophrenia, bipolar disorder, and severe depression.
H/T the Verge
Phillip Tracy is a former technology staff writer at the Daily Dot. He's an expert on smartphones, social media trends, and gadgets. He previously reported on IoT and telecom for RCR Wireless News and contributed to NewBay Media magazine. He now writes for Laptop magazine.